An Analysis of a Vogt-Koyanagi-Harada Disease Case in a Philippine Tertiary Hospital
Keywords:
Vogt-Koyanagi-Harada Disease (VKHD); Vitiligo; Bilateral granulomatous panuveitis; Autoimmune disorderAbstract
Vogt-Koyanagi-Harada disease (VKHD) is a defined as a bilateral granulomatous panuveitis that affects pigmented structures, such as the eye, inner ear, meninges, skin and hair. Up until this point, the exact pathogenesis is still a matter of inquiry. The most accepted mechanism involves autoimmune reaction among tissues that contains melanocytes. This disease
has been described to have four stages: prodromal, acute uveitic, convalescent and chronic/recurrent stage, all of which affecting pigmented structures in the body. Early diagnosis and meticulous use of steroids has remained as the mainstay treatment, however, poor prognosis for individuals who presented with complications in the initial consultation has been associated with a poor final visual acuity. The main objective of presenting this classic case of Vogt-Koyanagi-Harada disease is
describing its chronic systemic course, and the possible medical and surgical management for the disease and its complications
References
Rao NA, Gupta A, Dustin L, et al. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. Ophthalmology. 2010; 117(3): 591-599. doi: 10.1016/j.ophtha.2009.08.030
Castillo TR, Noche RR, Fajardo RV. Vogt – Koyanagi – Harada disease in the Philippines. Philippine Journal of Ophthalmology. 1998; 23(4): 159-162.
Herbort CP, Mochizuki M. Vogt-Koyanagi-Harada disease: In-quiry into the genesis of a disease name in the historical context of Switzerland and Japan. Int Ophthalmol. 2007; 27(2-3): 67-79. doi: 10.1007/s10792-007-9083-4
Matsuda H. Electron microscopic studies on Vogt-Koyanagi-Harada syndrome and sympathetic ophthalmia with special refer-ence to the melanocyte. Nippon Ganka Gakkai Zasshi. 1970; 74(9): 1107-1112.
Hammer H. Cellular hypersensitivity to uveal pigment con-firmed by leucocyte migration tests in sympathetic ophthalmitis and the Vogt-Koyanagi-Harada syndrome. Br J Ophthalmol. 1974 ; 58(9): 773-776.
Damico FM, Bezerra FT, Silva GC, Gasparin F, Yamamoto JH. New insights into Vogt-Koyanagi-Harada disease. Arq Bras Oftal-mol. 2009; 72(3): 413-420. Submit your article to this journal | https://openventio.org/submit-manuscript/ 4 Marcelo TT and Iguban EB
Imai Y, Sugita M, Nakamura S, Toriyama S, Ohno S. Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada’s disease. Curr Eye Res. 2001; 22(4): 312-318.
Rao NA. Pathology of Vogt-Koyanagi-Harada disease. Int Oph-thalmol. 2007; 27(2-3): 81-85. doi: 10.1007/s10792-006-9029-2
Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel. Am J Ophthalmol. 2000; 130(4): 492-513.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in The Ophthalmology (TOOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
